Home›People›Kenneth Bahk
KB

Kenneth Bahk

Director at Inflammatix.

Director
Updated Nov 2, 2026·Latest SEC filing Mar 24, 2021·Suggest an edit

About Kenneth Bahk

Form D filings for Inflammatix from 2020 to 2021 list Kenneth Bahk as director.

Kenneth Bahk first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Kenneth Bahk in the role, so the role may have started earlier or lasted longer.

Inflammatix, Inc.
Director
2020 – 2021 · Sunnyvale, CA
Inflammatix helps emergency teams identify infection type and illness severity from the body's immune response.

Key Colleagues at Startups

The people Kenneth Bahk works with at each company, as listed on that company's latest Form D.

Inflammatix, Inc. · Form D, Mar 24, 2021
MR
JK
Justin Kao
Director
Timothy Sweeney
Timothy Sweeney
Co-Founder and CEO, director
Steven Tablak
Steven Tablak
Former Chairman and CEO, GeneWeave
David Persing
David Persing
EVP/Chief Medical Officer, Cepheid and director

Sources

  1. SECInflammatix, Inc. Form D, filed Mar 24, 2021